{
    "clinical_study": {
        "@rank": "46803", 
        "arm_group": [
            {
                "arm_group_label": "The pops-titration group", 
                "arm_group_type": "Experimental", 
                "description": "The titration method uses power that is titrated according to the audible \"pop\"."
            }, 
            {
                "arm_group_label": "The slow-coagulation group", 
                "arm_group_type": "Experimental", 
                "description": "The slow-coagulation group utilize the low-energy using the Gaasterland's slow-coagulation technique"
            }
        ], 
        "brief_summary": {
            "textblock": "-  Transcleral cyclophotocoagulation (TSCPC) has long been used as refractory glaucoma\n           management and is very easy to learn and easy to perform.\n\n        -  Recent advances in laser technology; the role of TSCPC is being expanded because it has\n           benefits of noninvasive glaucoma procedure.\n\n        -  The titration (pops), the fixed high-energy, and the fixed-low energy\n           (slow-coagulation) are three energy delivery techniques.\n\n        -  The present study would report on the outcome (efficacy and safety) of the\n           slow-coagulation versus the titration method in treatment of refractory glaucoma with\n           dark iris.\n\n        -  The results would provide reliable evidences to supplement clinical judgment when\n           making a decision in favor of each treatment method for glaucoma patients."
        }, 
        "brief_title": "the Pops-titration Versus the Slow-coagulation Cyclophotocoagulation in Treatment of Refractory Glaucoma", 
        "completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Glaucoma", 
            "Intraocular Pressure"
        ], 
        "condition_browse": {
            "mesh_term": "Glaucoma"
        }, 
        "detailed_description": {
            "textblock": "-  Several protocols afford delivery of the \"optimum\" dose of laser energy per session\n           necessary to achieve a long-term effective ocular hypotensive response balancing risks\n           related to a high energy treatment and risks related to retreatment due to suboptimum\n           dose delivery.\n\n        -  There are two main approaches to delivering laser energy, the pops-titration method and\n           the fixed energy method that are the fixed-high and low-energy (the Gaasterland's\n           slow-coagulation technique).\n\n        -  Of particular interest is which laser energy delivery method (slow-coagulation versus\n           pops-titration) affords the optimal dose of photocoagulation necessary to achieve an\n           effective long-term intraocular pressure (IOP) reduction while minimizing the risk of\n           adverse events related to overtreatment and retreatments especially in refractory\n           glaucomatous eyes with dark iris color."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Eyes with no visual potential and very high intraocular pressure (on maximal medical\n             treatment) in which the intraocular pressure will probably cause corneal\n             complications\n\n          -  Eyes with no visual potential and very high intraocular pressure (on maximal medical\n             treatment) in which the intraocular pressure cause eye pain and need pain relief\n\n          -  Eyes with minimal useful vision and intraocular pressure over the target intraocular\n             pressure\n\n          -  Eyes in which trabeculectomy with mitomycin-C and/or drainage implants have a high\n             probability of failure\n\n          -  Eyes in which trabeculectomy with mitomycin-C and/or drainage implants have\n             previously failed\n\n          -  Patient refuses to undergo more aggressive intraocular surgery\n\n          -  Patients whose general medical condition precludes invasive surgery\n\n        Exclusion Criteria:\n\n          -  The visual acuity in the fellow eye is no light perception\n\n          -  Have previously been treated by the transcleral cyclophotocoagulation\n\n          -  Allergy to anesthetic medication\n\n          -  Can not measure the intraocular pressure by the applanation method"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "90", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 17, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01774227", 
            "org_study_id": "EC 56-094-02-1-2"
        }, 
        "intervention": [
            {
                "arm_group_label": "The pops-titration group", 
                "description": "The energy delivery is started at a low level and is increased in intervals till an audible pop is heard, following which the power is reduced downward until the pops are no longer audible, then the treatment is completed at these parameters", 
                "intervention_name": "The pops-titration group", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "The slow-coagulation group", 
                "description": "The Gaasterland's slow-coagulation energy delivery technique using the lower power for the longer duration.", 
                "intervention_name": "The slow-coagulation group", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Refractory glaucoma", 
            "Transcleral cyclophotocoagulation (TSCPC)", 
            "Dark iris", 
            "Pops-titration", 
            "Slow-coagulation"
        ], 
        "lastchanged_date": "November 27, 2013", 
        "location": {
            "contact": {
                "email": "kweerawat@hotmail.com", 
                "last_name": "Weerawat Kiddee, MD", 
                "phone": "+66874954626"
            }, 
            "facility": {
                "address": {
                    "city": "Hatyai", 
                    "country": "Thailand", 
                    "state": "Songkhla", 
                    "zip": "90110"
                }, 
                "name": "Ophthalmology Department, Prince of Songkla University"
            }, 
            "investigator": {
                "last_name": "Weerawat Kiddee, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Thailand"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomized Trial of the Pops-titration Versus the Slow-coagulation Energy Delivery Technique on the Outcome of Diode Laser Transcleral Cyclophotocoagulation in Treatment of Refractory Glaucoma With Dark Iris", 
        "overall_contact": {
            "email": "kweerawat@hotmail.com", 
            "last_name": "Weerawat Kiddee, MD", 
            "phone": "+66874954626"
        }, 
        "overall_official": {
            "affiliation": "Prince of Songkla University", 
            "last_name": "Weerawat Kiddee, MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Thailand: Ethical Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Success rate defined as the proportion of eyes achieving an intraocular pressure between 6 and 21mmHg with or without topical antiglaucoma medication  at the final follow up visit.", 
            "measure": "Success rate", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01774227"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Prince of Songkla University", 
            "investigator_full_name": "Weerawat Kiddee", 
            "investigator_title": "Dr.Weerawat Kiddee", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Response rate defined as the proportion of eyes achieving an intraocular pressure between < 22 mmHg or > 30% drop in an intraocular pressure with or without topical antiglaucoma medication at the final follow up visit.", 
                "measure": "Response rate", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "description": "Cyclodiode efficacy index defined as the ratio of response rate to the mean number of the treatment session.", 
                "measure": "Cyclodiode efficacy index", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "description": "Failure rate defined as the proportion of eyes developed hypotony or phthisis bulbi or need to repeat treatment for more than 2 laser sessions.", 
                "measure": "Failure rate", 
                "safety_issue": "Yes", 
                "time_frame": "12 months"
            }
        ], 
        "source": "Prince of Songkla University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Prince of Songkla University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}